InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by VAN NOSTRAND ROBERT L, Director. Insider active across 2 companies, notably Intra-Cellular Therapies, Inc.. In total, 9 filings have been logged. The latest transaction was disclosed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€6,963126 shares@ €55.263715.0% of flow
Common Stock
SEC:0001209191-22-022323:0·
01,900 shares0
Common Stock
SEC:0001104659-22-010397·
01,900 shares0
Common Stock
SEC:0001104659-22-010397:0·
€6,840148 shares@ €46.216234.7% of flow
Common Stock
SEC:0001209191-22-001347·
€6,840148 shares@ €46.216214.7% of flow
Common Stock
SEC:0001209191-22-001347:0·
€6,925215 shares@ €32.208835.1% of flow
Common Stock
SEC:0001209191-21-058949·
€6,925215 shares@ €32.208814.9% of flow
Common Stock
SEC:0001209191-21-058949:0·
€5,956173 shares@ €34.427630.2% of flow
Common Stock
SEC:0001209191-21-045038·
€5,956173 shares@ €34.427612.8% of flow
Common Stock
SEC:0001209191-21-045038:0·
9 of 9 declarations
About VAN NOSTRAND ROBERT L
Robert L. Van Nostrand is a Board Member of Intra-Cellular Therapies, Inc. and SELLAS Life Sciences Group, Inc. As a board member, he participates in the governance of the companies and strategic decision-making. Robert leverages his experience to help guide the direction of the companies and ensure compliance with regulatory standards.
